University of Maryland School of Medicine, Baltimore, MD, USA.
J Thorac Cardiovasc Surg. 2012 Nov;144(5):1061-6. doi: 10.1016/j.jtcvs.2012.08.023.
Robotic total endoscopic coronary artery bypass grafting (TECAB) has been under development for 10 years. With increasing experience and technological improvement, double-vessel TECAB has become feasible. The aim of the present study was to compare the current outcomes of single- and double-vessel TECAB.
Between 2001 and 2011, 484 patients underwent TECAB by 4 surgeons at 2 institutions. The median patient age was 60 years (range, 31-90), and the median European System for Cardiac Operative Risk Evaluation was 2 (range, 0-13). Single-vessel (n = 334) and double-vessel (n = 150) procedures were performed using the da Vinci, da Vinci S, and da Vinci Si robotic systems.
Compared with the single-vessel procedure, double-vessel TECAB required a longer operative time (median, 375 minutes; range, 168-795; vs median, 240; range, 112-605; P < .001) and had an increased conversion rate to a larger thoracic incision (31/150 [20.7%] vs 31/334 [9.3%]; P < .001). The median ventilation time was 10 hours (range, 0-288) for double-vessel versus 8 hours (range, 0-278) for single-vessel procedures (P = .006). The hospital stay was comparable, with 6 days (range, 2-27) for double-vessel TECAB and 6 days (range, 2-33) for single-vessel TECAB (P = .794). Perioperative mortality was 0.3% (1/334) with single-vessel TECAB and 2.0% (3/150) with double-vessel TECAB (P = .090). Freedom from major adverse cardiac and cerebral events at 5 years was similar after double- and single-vessel TECAB (73.5% vs 83.1%, P = .150). The 5-year survival was 95.8% and 93.9% (P = .708).
Double-vessel TECAB appears feasible and reproducible. The operative times were longer and the conversion rates to a larger thoracic incision were greater than with single-vessel TECAB. Also, the postoperative ventilation time was longer. Other perioperative morbidity and mortality and the recovery time and long-term clinical outcomes, however, were comparable.
机器人全内镜冠状动脉旁路移植术(TECAB)已经发展了 10 年。随着经验的增加和技术的进步,双血管 TECAB 已经成为可能。本研究的目的是比较单支和双支 TECAB 的目前结果。
2001 年至 2011 年,4 名外科医生在 2 家机构对 484 例患者进行了 TECAB。患者的中位年龄为 60 岁(范围,31-90 岁),欧洲心脏手术风险评估系统的中位数为 2(范围,0-13)。使用达芬奇、达芬奇 S 和达芬奇 Si 机器人系统进行单支(n=334)和双支(n=150)手术。
与单支血管 TECAB 相比,双支血管 TECAB 需要更长的手术时间(中位数,375 分钟;范围,168-795;与中位数,240;范围,112-605;P<.001),并且向更大的胸腔切口转化的比例更高(31/150[20.7%]比 31/334[9.3%];P<.001)。双支血管 TECAB 的中位通气时间为 10 小时(范围,0-288),单支血管 TECAB 为 8 小时(范围,0-278)(P=.006)。住院时间相似,双支血管 TECAB 为 6 天(范围,2-27),单支血管 TECAB 为 6 天(范围,2-33)(P=.794)。单支血管 TECAB 的围手术期死亡率为 0.3%(1/334),双支血管 TECAB 的围手术期死亡率为 2.0%(3/150)(P=.090)。双支血管和单支血管 TECAB 术后 5 年无主要心脏和脑不良事件的生存率分别为 73.5%和 83.1%(P=.150)。5 年生存率分别为 95.8%和 93.9%(P=.708)。
双支血管 TECAB 似乎是可行且可重复的。手术时间较长,向更大的胸腔切口转化的比例也高于单支血管 TECAB。此外,术后通气时间也较长。然而,其他围手术期发病率和死亡率以及恢复时间和长期临床结果相似。